安捷凯在线客服
- 客服:
- 电话: 13061953619
- 微信:
DB2115 (tertahydrochloride) 是骨髓主调节因子 PU.1 的有效抑制剂。DB2115 (tertahydrochloride) 具有治疗癌症的潜力,包括白血病等血液系统癌症,以及与PU. 1 功能障碍相关的其他疾病 (信息来自专利 WO2017223260A1,compound DB2115)。
DB2115 (tertahydrochloride) is a potent inhibitor of myeloid master regulator PU.1. DB2115 (tertahydrochloride) has the potential for the treatment of cancers, including hematologic cancers such as leukemia, as well as other conditions associated with PU. 1 dysfunction (extracted from patent WO2017223260A1, compound DB2115) [1].
[1]. W. David Wilson, et al. Pu.1 inhibitors. Patent WO2017223260A1.
动态评分
0.0